Company intelligence / Profile preview
Yaso Therapeutics
Frisco, Texas, United Statesyasotherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Yaso Therapeutics is developing topical drug products containing PPCM to treat and prevent all drug-resistant strains of gonorrhea and herpes simplex, as well as to prevent unplanned pregnancies. The company has secured worldwide rights to PPCM and has advanced at least one product from benchtop research to an authorized IND. As of March 2025, its lead programs are in preclinical or early clinical stages.[1][4][5][6]
- Therapeutic areas
- Women's HealthInfectious Diseases
- Modalities
- Small molecules (specifically polyanionic drugs such as PPCM)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Yaso Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yaso Therapeutics.